October 18, 2011Open Access

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

On the basis of 5-year follow-up data, postoperative adjuvant therapy with S-1 was confirmed to improve overall survival and relapse-free survival in patients with stage II or III gastric cancer who had undergone D2 gastrectomy.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Mitsuru Sasako

Yodogawa Christian Hospital

Shinichi Sakuramoto

Saitama International Medical Center

Hitoshi Katai

Tachikawa Hospital

Journals

Journal of Clinical Oncology

Actions

Institutions

National Cancer Center Hospital East

Kitasato University

Hyogo Medical University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study